A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 39/39 (2006.01)
Patent
CA 2564470
The present invention provides novel vaccine formulations for the treatment of cancer antigens. The vaccine comprises a modified MAGE-3 antigen, a NY-ESO-1 antigen, and an adjuvant comprising a saponin and a immunostimulatory oligonucleotide.
L'invention concerne de nouvelles formulations de vaccins pour le traitement des antigènes cancéreux. Le vaccin comprend un antigène MAGE-3, un antigène NY-ESO-1, et un adjuvant comprenant de la saponine et un oligonucléotide immunostimulant.
Brichard Vincent
Bruck Claudine Elvire Marie
Meaders Melinda
Palmantier Remi M.
Glaxosmithkline Biologicals S.a.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Mage-3 and ny-eso-1 based polyvalent vaccine for cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mage-3 and ny-eso-1 based polyvalent vaccine for cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mage-3 and ny-eso-1 based polyvalent vaccine for cancer... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1423474